Afghanistan vs Serbia: HIV/AIDS deaths averted by antiretroviral therapy
Afghanistan
123.58 deaths
in 2024
Serbia
136.49 deaths
in 2024
Afghanistan rank
123rd
Serbia rank
120th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Afghanistan
- Serbia
How they compare
Serbia currently reports 136.49 deaths against 123.58 deaths in Afghanistan, a difference of 12.91 deaths.
That makes Serbia's figure about 1.1 times Afghanistan's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Serbia ahead.
Afghanistan ranks 123rd and Serbia ranks 120th of 157 countries.
Serbia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Afghanistan | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 0.4161 deaths | 52.91 deaths | 52.49 deaths | Serbia |
| 2010s | 58.68 deaths | 102.45 deaths | 43.77 deaths | Serbia |
| 2020s | 108.95 deaths | 130.42 deaths | 21.47 deaths | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Afghanistan or Serbia?
- Serbia, at 136.49 deaths against 123.58 deaths in Afghanistan as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Afghanistan and Serbia?
- 12.91 deaths, with Serbia ahead.
- How many years of comparable data are there for Afghanistan and Serbia?
- 35 years are reported by both, from 1990 to 2024.
- How do Afghanistan and Serbia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Afghanistan ranks 123rd and Serbia ranks 120th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.